Can malignant prostate cancer be cured?

The treatment of malignant tumors is very complicated, and the best treatment plan needs to be determined based on the patient's specific condition. The same is true for the treatment of prostate cancer, but some basic treatment methods are indispensable, such as diet in auxiliary treatment measures. So can malignant prostate cancer be cured? Let's take a look at the following introduction.

The chances of cure for late-stage prostate cancer vary depending on the severity of the patient's condition. However, patients should not blindly seek medical treatment when choosing a hospital and treatment method. They should choose a regular tertiary hospital or a hospital specializing in cancer treatment for treatment. Patients can take biological treatments to improve the survival rate of prostate cancer patients and prolong their lifespan.

The following is a summary of common treatments for prostate cancer:

Chemotherapy: Chemotherapy is a common adjuvant treatment for advanced prostate cancer. It is mainly used for patients who have undergone surgery or radiotherapy and whose local tumors have been eliminated. Chemotherapy drugs are used to eliminate potential small lesions that are currently undetectable. Chemotherapy drugs alone cannot cure the primary lesions. Adjuvant chemotherapy can prolong the patient's survival after surgery. Experiments have found that the most sensitive chemotherapy drug for prostate cancer is cyclophosphamide.

Radiotherapy: Radiotherapy has a good therapeutic effect on prostate cancer and can significantly reduce the size of prostate tumor lesions. It is mainly used for patients who have difficulty in surgical resection or cannot be removed but have not yet metastasized to distant sites. Radiotherapy is divided into internal radiation therapy, external radiation therapy and palliative radiotherapy, among which external radiation therapy is the most commonly used.

Surgical treatment: Surgical treatment is currently the preferred treatment for prostate cancer. However, since prostate cancer is often discovered in the late stage, the best time for surgery is often missed. Most prostate cancer patients are elderly, and radical prostate surgery often causes serious damage, so the indications and contraindications should be strictly controlled. In recent years, minimally invasive treatment of transurethral transurethral resection of the prostate has been newly developed, with the aim of reducing the degree of obstruction of the bladder neck and improving the symptoms of dysuria, thereby improving the quality of life of patients.

After surgical resection of prostate cancer, care is also required because malignant tumors tend to recur repeatedly, and prostate cancer is no exception. It is a disease with a relatively high recurrence rate among various malignant tumors. Therefore, attention must be paid to all aspects of postoperative contraindications.